Supera-CBD binds to and inhibits opioid receptors, comparing it side by side with plant-based CBD. Opioid receptors are G protein-coupled receptors, widely expressed in the brain, spinal cord, peripheral neurons, and digestive tract.
Supera-CBD is non-toxic and approximately 7-8X more effective than plant-derived CBD in reducing MAO-A and MAO-B, which play a role in substance addiction, in a dose-dependent manner.
INHIBITS OPIOID RECEPTORS
© 2022 MyMD Pharmaceuticals™. All Right Reserved
Building on CBD’s enormous pre-existing market acceptance and the FDA’s declared receptiveness to moving forward in this space, Supera-CBD is positioned to become a prescription drug alternative to unregulated CBD.
POTENTIALLY MORE EFFECTIVE THAN CBD
See the poster presented at the 3rd Annual Neuroimmunology Drug Development Conference
*These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to treat, cure, prevent or mitigate disease.
✓ Works in minutes, lasts hours * ✓ Soothes muscles * ✓ Eases inflammation *
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.